GLAXOSMITHKLINE NEBRASKA recalls Prevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, 14 capsules per bottle in a carton containing 1 bottle
Glaxosmithkline Nebraska recalls Prevacid 24HR (Lansoprazole) 15mg capsules with CGMP deviations. Affected lots expire through 2021. Consumers should check product details and contact the manufacturer.
Recall notice
CGMP deviations
Contact the company & request your remedy
What happened, in plain English
Glaxosmithkline Nebraska has recalled Prevacid 24HR (Lansoprazole) 15mg delayed-release capsules due to manufacturing deviations. This recall affects specific lots of 1-bottle, 2-bottle, and 3-bottle cartons that were distributed between 2018 and 2021. The recall is for safety reasons related to potential quality issues in the production process. Read more at govinfonow.com/recall/39548-glaxosmithkline-nebraska-recalls-prevacid-24hr-capsules-due-to-manufacturing-deviations.
Source Summary by GovInfoNow · govinfonow.com/recall/39548-glaxosmithkline-nebraska-recalls-prevacid-24hr-capsules-due-to-manufacturing-deviations · Updated October 6, 2026 · FDA enforcement record: FDA #D-0088-2019
Cite this page
“Glaxosmithkline Nebraska Recalls Prevacid 24HR Capsules Due to Manufacturing Deviations.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39548-glaxosmithkline-nebraska-recalls-prevacid-24hr-capsules-due-to-manufacturing-deviations. Based on FDA recall #D-0088-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0088-2019%22&limit=1).
Why it’s dangerous
The recall is due to CGMP (Current Good Manufacturing Practice) deviations, which means the production process did not meet the required quality standards. This could potentially lead to the product not being safe or effective for use, though the exact risk to consumers is not specified in the recall notice.
Who’s affected
People who purchased Prevacid 24HR 15mg capsules from Glaxosmithkline Nebraska between 2018 and 2021 are affected. Those with the specific lot numbers listed in the recall are most at risk.
How to tell if you have this one
Check the product label for the NDC code (0067-6286-14 for 1-bottle, 0067-6286-28 for 2-bottle, 0067-6286-42 for 3-bottle) and the lot number. The recall includes specific expiration dates and lot numbers for each package size.
- Brand
Glaxosmithkline Nebraska- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code and lot number on the product label to determine if it's affected by this recall.
Questions people ask
Why is this product being recalled?
Glaxosmithkline Nebraska is recalling these Prevacid 24HR capsules due to CGMP deviations, which means the manufacturing process did not meet quality standards.
How do I know if my product is affected?
Check the NDC code (0067-6286-14 for 1-bottle, 0067-6286-28 for 2-bottle, 0067-6286-42 for 3-bottle) and lot number on the product label. The recall includes specific expiration dates and lot numbers for each package size.
What should I do if I have the recalled product?
The recall notice does not specify a remedy, so contact Glaxosmithkline Nebraska directly for further instructions.
Contact Glaxosmithkline Nebraska
We’ve drafted a message you can send Glaxosmithkline Nebraska to request your refund or repair — edit it as you like.
Subject: Recall D-0088-2019 — Glaxosmithkline Nebraska Glaxosmithkline Nebraska Hello, I own a Glaxosmithkline Nebraska that is covered by recall D-0088-2019 from Glaxosmithkline Nebraska. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0088-2019 (September 26, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0088-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.